| 1 |
31903737 | Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population. | 2020 Apr |
2 |
| 2 |
30412630 | Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin. | 2018 |
1 |
| 3 |
27852920 | Thrombin-Induced Inflammation in Human Decidual Cells Is Not Affected By Heparin. | 2017 Aug |
2 |
| 4 |
29066620 | Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor. | 2017 Dec 22 |
1 |
| 5 |
27258428 | Histones Induce the Procoagulant Phenotype of Endothelial Cells through Tissue Factor Up-Regulation and Thrombomodulin Down-Regulation. | 2016 |
1 |
| 6 |
27405066 | Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes. | 2016 Dec |
2 |
| 7 |
27566697 | Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. | 2016 Nov |
1 |
| 8 |
25969127 | Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy. | 2015 Sep |
1 |
| 9 |
24266905 | Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass. | 2014 Jan |
4 |
| 10 |
21159364 | Immunomodulatory drugs increase endothelial tissue factor expression in vitro. | 2011 Mar |
2 |
| 11 |
21946214 | Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB. | 2011 Dec |
3 |
| 12 |
22977511 | Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro. | 2011 Mar |
1 |
| 13 |
20431847 | Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. | 2010 Jun |
2 |
| 14 |
20434010 | Heparanase procoagulant effects and inhibition by heparins. | 2010 Apr |
1 |
| 15 |
19377079 | Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins. | 2009 Jun |
4 |
| 16 |
18645924 | Heparanase, tissue factor, and cancer. | 2008 Mar |
1 |
| 17 |
17167048 | Analysis of inhibition rate enhancement by covalent linkage of antithrombin to heparin as a potential predictor of reaction mechanism. | 2007 Jan |
2 |
| 18 |
16376423 | Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model. | 2006 Apr |
1 |
| 19 |
15718352 | Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma. | 2005 May |
3 |
| 20 |
15034796 | Tissue factor and fibrin in tumor angiogenesis. | 2004 Feb |
1 |
| 21 |
12801846 | Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells. | 2003 Jun |
1 |
| 22 |
12808176 | Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study. | 2003 Jul |
3 |
| 23 |
14686601 | Synthesis and evaluation of amphiphilic RGD derivatives: uses for solvent casting in polymers and tissue engineering applications. | 2003 Nov |
2 |
| 24 |
11991242 | Effects of a low molecular weight heparin, bemiparin, and unfractionated heparin on hemostatic properties of endothelium. | 2002 Jan |
1 |
| 25 |
12028043 | Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration. | 2002 Jun |
2 |
| 26 |
12586136 | Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. | 2002 Oct 1 |
1 |
| 27 |
12626202 | Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface. | 2002 Dec |
3 |
| 28 |
11254842 | Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. | 2001 Feb |
1 |
| 29 |
11342462 | Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. | 2001 May 15 |
1 |
| 30 |
11493478 | Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. | 2001 Aug 15 |
1 |
| 31 |
11772296 | Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. | 2001 Nov |
1 |
| 32 |
10828477 | Tissue factor pathway inhibitor levels in patients with homocystinuria. | 2000 Jun 1 |
1 |
| 33 |
10235445 | Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. | 1999 Apr |
4 |
| 34 |
10348708 | Effects of heparin and related sulfated polysaccharides on tissue factor expression induced by mitogenic and non-mitogenic factors in human vascular smooth muscle cells. | 1999 Jan |
4 |
| 35 |
10545520 | Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. | 1999 Nov |
1 |
| 36 |
10604885 | Heparin blunts endotoxin-induced coagulation activation. | 1999 Dec 21-28 |
3 |
| 37 |
10697424 | Coagulative and fibrinolytic activity in parietal thrombus of aortic aneurysm. | 1999 |
1 |
| 38 |
10844403 | Comparative inhibition of LPS-activated human monocyte-induced thrombin generation by unfractionated heparin and low molecular weight heparins. | 1999 Nov-Dec |
1 |
| 39 |
9459343 | A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis. | 1998 Jan |
1 |
| 40 |
9674734 | Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. | 1998 Jun |
6 |
| 41 |
9058497 | Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance. | 1997 Feb 1 |
1 |
| 42 |
9157959 | Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. | 1997 May |
1 |
| 43 |
9200337 | Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin. | 1997 |
1 |
| 44 |
8790153 | Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. | 1996 Sep |
1 |
| 45 |
8950777 | Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man. | 1996 Nov |
3 |
| 46 |
7803789 | Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. | 1995 Jan 1 |
1 |
| 47 |
8219221 | Characterization of the interactions between procoagulant albumin and human endothelial cells. | 1993 Nov 1 |
1 |
| 48 |
1346095 | Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides. | 1992 Jan 15 |
2 |
| 49 |
1705837 | Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. | 1991 Mar 15 |
1 |
| 50 |
1964669 | Heparin, monocytes, and procoagulant activity. | 1990 |
1 |